CM8®: The Science Behind Flexcin

Studied for its role in supporting a healthy inflammatory response,
mobility, and everyday joint comfort — found only in Flexcin.

What Is CM8®?

CM8® stands for Cetyl Myristoleate — a naturally occurring fatty acid ester researched for its role in supporting a healthy inflammatory response and normal joint function. It was first discovered in 1972 by Dr. Harry Diehl, a researcher at the National Institutes of Health. Dr. Diehl was awarded three U.S. patents for this discovery: Patent Nos. 4,049,824; 4,113,881; and 5,569,676. CM8 remains exclusive to the Flexcin formula.

Backed by Science.
Trusted in Practice.

Lubricates joints naturally

Supports a healthy inflammatory response

Exclusive to Flexcin

Clinical Study Results

Randomized, double-blind, placebo-controlled trial (n=382):

Placebo Group:

0 %

improvement

CM8 Group:

0 %

improvement

CM8 + Nutrients:

0 %

improvement

Improvement reflects participant self-assessment alongside clinical evaluation, lab and imaging. Individual results vary.

Source: Siemandi H., Townsend Letter for Doctors and Patients, 1997

Clean, Tested, and
Made to Strict Standards

CM8 is distilled and crystallized to remove inert compounds. Manufactured in the USA under strict GMP standards.